BRAINSWAY LTD/S (BWAY) Scheduled to Post Earnings on Wednesday

BRAINSWAY LTD/S (NASDAQ:BWAY) is scheduled to be posting its quarterly earnings results before the market opens on Wednesday, May 29th. Analysts expect BRAINSWAY LTD/S to post earnings of ($0.13) per share for the quarter.

NASDAQ:BWAY opened at $10.68 on Friday. BRAINSWAY LTD/S has a fifty-two week low of $10.30 and a fifty-two week high of $12.39.

A number of analysts have recently weighed in on the company. Raymond James assumed coverage on BRAINSWAY LTD/S in a research note on Monday, May 13th. They set an “outperform” rating and a $14.00 price objective for the company. Oppenheimer assumed coverage on BRAINSWAY LTD/S in a research note on Monday, May 13th. They set an “outperform” rating and a $17.00 price objective for the company. LADENBURG THALM/SH SH assumed coverage on BRAINSWAY LTD/S in a research note on Monday, May 13th. They set a “buy” rating and a $19.00 price objective for the company. Cantor Fitzgerald assumed coverage on BRAINSWAY LTD/S in a research note on Monday, May 13th. They set an “overweight” rating and a $17.00 price objective for the company. Finally, CIBC assumed coverage on BRAINSWAY LTD/S in a research note on Monday, May 13th. They set an “outperform” rating for the company. Five research analysts have rated the stock with a buy rating, The stock has a consensus rating of “Buy” and a consensus price target of $16.75.

WARNING: This piece of content was originally published by Enterprise Leader and is the property of of Enterprise Leader. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The original version of this piece of content can be viewed at https://theenterpriseleader.com/2019/05/24/brainsway-ltd-s-bway-scheduled-to-post-earnings-on-wednesday.html.

BRAINSWAY LTD/S Company Profile

Brainsway Ltd. engages in the development and provision of technology solutions for non-invasive treatment of brain disorders in Israel and internationally. It offers deep transcranial magnetic stimulation systems for treating various conditions, including autism, Alzheimer's disease, bipolar disorders, chronic pains, depressive disorders, Parkinson's diseases, schizophrenia, smoking cessation, post-traumatic stress disorders, multiple sclerosis, obsessive compulsive disorders, and stroke rehabilitation.

Featured Story: What is an overbought condition?

Receive News & Ratings for BRAINSWAY LTD/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BRAINSWAY LTD/S and related companies with MarketBeat.com's FREE daily email newsletter.